JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY)

• Articles • Previous Articles     Next Articles

Expression and significance of p21, p73 and PTEN in multiple primary cancers of the head and neck

HUANG Fang1,ZHU Cong-yue2   

  1. 1. Department of Otorhinolaryngology, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000;2. Department of Otorhinolaryngology, Huai′an Second People′s Hospital,Huai′an
  • Received:1900-01-01 Revised:1900-01-01 Online:2007-10-24 Published:2007-10-24
  • Contact: HUANG Fang

Abstract: Objective: To investigate the effects of p21, p73 and PTEN expressions in multiple primary cancers of the head and neck. Method: Expressions of p21, p73 and PTEN were determined by the S-P immunohistochemical technique in 42 samples of multiple primary cancer tissues, 42 cases of marched single cancer tissues of the head and neck, and 30 cases of normal epithelial tissues of the head and neck. Results: Positive expression rates of p21, p73 and PTEN in multiple primary cancer tissues and single cancer tissues of the head and neck were 69.05%, 57.14%, 71.43% and 76.19%, 40.48%, 76.19%, respectively, and those in normal epithelial tissues were 96.66%, 13.33% and 100.00%. The loss expression rates of p21 and PTEN and the over-expression rates of p73 in multiple primary cancer tissues and single cancer tissues of the head and neck were all significantly higher than those in normal epithelial tissues(P<0.05), but no significant differences were found between multiple primary cancer tissues and single cancer tissues. Conclusion: The loss of expression of p21 and PTEN and the upregulated expression of p73 may play important roles in tumor genesis of multiple primary cancer and single cancer of the head and neck, but no differences have been found till now between multiple primary cancer and single cancer.

Key words: Multiple primary cancers, Head and neck neoplasms, p21, p73, PTEN, Immunohistochemistry

CLC Number: 

  • R739.91
[1] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[2] HUANG Jiali, LIU Ziqi, XU Juan, CHEN Xi, ZHANG Liqing, ZHOU Han. Clinical and prognostic analysis of spindle cell squamous carcinoma of pharynx [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 94-100.
[3] LI Gui, YANG Yanli, LI Donghai, YAN Xiuying. Adult orbital xanthogranulomatous disease with clinicopathological analysis report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 80-85.
[4] LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce. Rosai-Dorfman disease of the bilateral neck and nasopharynx: a case report and review of related cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 108-114.
[5] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[6] YANG Kaiyan, TANG Fengzhu, QIN Qicai, LI Xuxiang, FENG Dayi, NONG Fengjing, YANG Qiuyun. Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 18-25.
[7] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
[8] CHENG Yao, ZHANG Zhen, YANG Ji, FENG Chengmin, DENG Qicheng, ZHANG Xi, ZHAO Rui, ZHU Xin, WU Junzhi, LIU Hai, DENG Shishan. Expression and clinical significance of CIP2A in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 40-44.
[9] XUE Gang, SUN Xinmin, LIN Xu, WU Jingfang. Expression and clinical significance of the KCNK5 double-pore potassium channel protein in papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 64-69.
[10] . Expression of cyclin E2 in hypopharyngeal cancer and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 132-137.
[11] JIANG Ningning, WANG Penglai, YUAN Changyong, HUANG Xiaofeng, JIANG Changwei, LIU Zongxiang,SUN Tiezhong. The expression and significance of metastasis suppressor 1 protein in tongue squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 64-67.
[12] Kun LIU,Xinxin ZHANG. Progress in clinical research on circulating tumor cells in squamous cell carcinoma of the head and neck [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 18-24.
[13] LUO Tongyong, YANG Huaqing, YUE Shengqing, JIA Quanfan, YUAN Long. Panitan single resistance and taxol as the first-line treatment of recurrent or metastatic head and neck cancer: a phase Ⅱ study [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 71-75.
[14] Xi CHEN,Mingzhe QIAO. Progress of immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 42-48.
[15] WEI Dongmin, LI Wenming, QIAN Ye, LIU Dayu, LEI Dapeng, PAN Xinliang. Lateral neck dissection [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 115-115.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!